Business plans from dispensaries ---hospitals to apple all have the same general management and business direction. Differen fields but the goal is the same market a product ie doctors...computers, cannabis etc. The business plan of a bio tech trying to get FDA approval is essentially a hail marry pass. Product gets approval or it doesn't...stock goes up or down. Which is what cbis is doing, and their communication with investors isn't that great which you can expect from a bio tech who just wants the operating money. Talking to Ir is only going to get you so far. There is promise but still a downside. With all the money they have spent though they could have marketed a supplement or something by now. You could put their hemp oil Into a jell pill and maket it as a supplement at gnc. I think we will be happy with cbis long term but I would like to see somethIng short term as well. Jmo
News 
Market Data 
Discover 
AI
